ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1641 • 2018 ACR/ARHP Annual Meeting

    Spa-Net: A Disease-Specific Integrated Ehealth System and Quality Registry for Spondyloarthritis in Daily Practice in the Netherlands

    Casper Webers1,2, Esther Beckers1,2, Yvonne van Eijk-Hustings1,2, Harald Vonkeman3, Mart van de Laar3, Piet van Riel4, Monique Efde5, Annelies Boonen1,2 and Astrid van Tubergen1,2, 1Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 2Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands, 3Department of Rheumatology, Medisch Spectrum Twente, Enschede, Netherlands, 4Department of Rheumatology, Bernhoven, Uden, Netherlands, 5Department of Rheumatology, VieCuri Medical Center, Venlo, Netherlands

    Background/Purpose: Regular and personalised monitoring of disease activity, functioning, medication use and side effects is essential to improve and maintain patients’ health-related quality of life…
  • Abstract Number: 1642 • 2018 ACR/ARHP Annual Meeting

    Systematic Screening of Comorbidities Improves Vaccination Rates, Skin Cancer Screening and Vitamin D Supplementation in Patients with Axial Spondyloarthritis: Results of a Prospective, Controlled ,One Year Randomised Trial

    Anna Molto1, Adrien Etcheto2, Serge Poiraudeau3, Laure Gossec4, Pascal Claudepierre5, Martin Soubrier6, Françoise Fayet7, Daniel Wendling8, Philippe Gaudin9, Emmanuelle Dernis10, Sandrine Guis11, Sophie Pouplin12, Adeline Ruyssen-Witrand13 and Maxime Dougados14, 1Hôpital Cochin, Department of Rheumatology, Paris Descartes University, Paris, France, 2Department of Rheumatology, Paris Descartes University, Hôpital Cochin, Paris, France, 3Univ. Paris Descartes, PRES Sorbonne Paris, INSERM UMR-S 1153 et Institut fédératif de recherche sur le handicap, Paris, France, Paris, France, 4Rhumatologie, Médecine Sorbonne Université, Pitié-Salpétrière Hospital, Paris, France, 5Hôpital Henri Mondor, Créteil, France, 6Rheumatology, Department of Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 7CHU Gabriel Montpied, Clermont Ferrand, France, 8Rheumatology, University Hospital - Bourgogne Franche Comté University, Besançon, France, 9Grenoble University Hospital, France, Grenoble, France, 10Service de Rhumatologie, CH du Mans, Le Mans, France, 11Rheumatology Department, CHU, Marseile, France, 12Rheumatology Department & Inserm 905, Department of Rheumatology, Rouen University Hospital & Inserm 905, Institute for Biomedical Research, University of Rouen, Rouen, France, 13Rheumatology, Purpan Hospital, Toulouse III University, Toulouse, France, 14Paris Descartes University, Hôpital Cochin, Paris, France

    Background/Purpose: Specific recommendations for the detection/prevention of comorbidities have been proposed for patients with SpA. However, we know that often a gap exists between recommendation…
  • Abstract Number: 1643 • 2018 ACR/ARHP Annual Meeting

    Psa Impact of Disease Questionnaire Scores Are Correlated with Disease Activity, As Measured By Cdapsa in Patients with Psa

    Ana-Maria Orbai1, Klaus Krüger2, Frank Behrens3, Uta Kiltz4, Benoit Guerette5, Lillian Mellars5, Michele Brunori5 and Jürgen Wollenhaupt6, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Medical Centre of Rheumatology, Munich, Germany, 3Clinical Research Rheumatology and Fraunhofer Institute IMETranslation, Goethe University, Frankfurt, Germany, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Celgene Corporation, Summit, NJ, 6Schön-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany

    Background/Purpose: We examined clinical correlations between disease activity, as measured with the Clinical Disease Activity for PsA (cDAPSA) components and PsA life impact/health-related quality of…
  • Abstract Number: 1644 • 2018 ACR/ARHP Annual Meeting

    Improvement in Morning Stiffness in Subjects with Psa Is Associated with Improvements in Pain, Physical Function, and Patient Global Response to Treatment

    Ana-Maria Orbai1, Jessica Walsh2, Peter Nash3, Lichen Teng4, Benoit Guerette4 and Rieke Alten5, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Utah School of Medicine, Salt Lake City, UT, USA, Salt Lake City, UT, 3University of Queensland, Brisbane, Australia, 4Celgene Corporation, Summit, NJ, 5Schlosspark-Klinik University Medicine, Berlin, Germany

    Background/Purpose: Stiffness is an important component of inflammatory arthritis and plays a role in PsA flare. Patients with inflammatory arthritis report difficulty with activities, “slowing…
  • Abstract Number: 1645 • 2018 ACR/ARHP Annual Meeting

    Clinical Features of Axial Spondyloarthritis Patients Diagnosed in Secondary Versus a Tertiary Hospital

    Ann-Sophie De Craemer1,2, Thomas Renson1,2, Philippe Carron1,2, Peggy Jacques1,2, Rik Joos1,3,4, Jan Lenaerts5,6, Lieve Gyselbrecht7, Filip van Den Bosch1,2 and Dirk Elewaut1,2, 1Department of Rheumatology, Ghent University Hospital, Ghent, 9000, Belgium, 2VIB Inflammation Research Center, Ghent, 9000, Belgium, 3Department of Rheumatology, Antwerp University Hospital, Edegem, 2650, Belgium, 4Department of Rheumatology, ZNA Jan Palfijn, Merksen, 2170, Belgium, 5Reuma Institute Hasselt, Hasselt, 3500, Belgium, 6Department of Rheumatology, Leuven University Hospital, Leuven, 3000, Belgium, 7Department of Rheumatology, ASZ Aalst, Aalst, 9300, Belgium

    Background/Purpose: Diagnosis of axial spondyloarthritis (axSpA) often relies on a positive MRI of the SI joints. However, pitfalls in interpretation of MRI images were recently…
  • Abstract Number: 1646 • 2018 ACR/ARHP Annual Meeting

    Prevalence of Spondyloarthritis in Patients with Anterior Uveitis

    Kristyna Bubova1,2, Monika Gregová1,2, Katerina Zegzulkova1,2, Karel Pavelka1,2, Jarmila Heissigerova3,4 and Ladislav Šenolt2,5, 1Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 3Department of Ophthalmology, First Faculty of Medicine, Charles University, Prague Czech Republic, Prague, Czech Republic, 4Department of Ophthalmology, General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic, 5First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

    Background/Purpose: Anterior uveitis (AU) is a common extraarticular manifestation in spondyloarthritis (SpA). The disease can precede the typical axial and peripheral features. Additionally, some studies…
  • Abstract Number: 1647 • 2018 ACR/ARHP Annual Meeting

    Uveitis, the Most Faithful Partner of Axial Spondyloarthritis

    Dafne Capelusnik1, Malena Cavalieri2, Roger Rolon Campuzano3, Maria Celeste Orozco4, Natalia Zamora5, Emilce E Schneeberger6 and Gustavo Citera7, 1Reumatology, Instituto de Rehabilitación Psicofísica, Argentina, CABA, Argentina, 2Reumatologia, Instituto de Rehabilitación Psicofísica, CABA, Argentina, 3Section of Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, 4Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 5Reumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, Buenos Aires, Argentina, 6Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 7Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina

    Background/Purpose: Acute Anterior Uveitis (AAU) is the most frequent extra-articular manifestation in axial Spondyloarthritis (axSpA), with an overall prevalence of 32.7%. It is a manifestation…
  • Abstract Number: 1648 • 2018 ACR/ARHP Annual Meeting

    Smoking Status in Patients with Psoriasis and Psoriatic Arthritis: An Irish Perspective

    Conor Magee1, Oliver FitzGerald2, Flora Farkas1, Natsumi Ikumi1, Phil Gallagher3, Agnes Szentpetery4 and Brian Kirby5, 1Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, 2Department of Rheumatology, St Vincent's University Hospital and Conway Institute, University College Dublin, Ireland, Dublin, Ireland, 3St. Vincent's University Hospital, Department of Rheumatology, Dublin, Ireland, 4Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, 5Dermatology, St. Vincent's University Hospital, Dublin, Ireland

    Background/Purpose: The BIOmarkers of COMorbidities (BIOCOM) in psoriasis study is a longitudinal study which aims to identify clinical, genetic or protein biomarker features associated with…
  • Abstract Number: 1649 • 2018 ACR/ARHP Annual Meeting

    Cohort Identification of Axial Spondyloarthritis in a Large Healthcare Dataset: Current and Future Methods

    Gopi Penmetsa1 and Jessica Walsh2, 1University of Utah, Salt Lake City, UT, 2University of Utah School of Medicine, Salt Lake City, UT, USA, Salt Lake City, UT

    Background/Purpose: Big data research is important for studying uncommon diseases in real-world settings. Most big data studies in axial spondyloarthritis (axSpA) have been limited to…
  • Abstract Number: 1650 • 2018 ACR/ARHP Annual Meeting

    Subclinical Atheromatosis and Estimation of Cardiovascular Risk in Patients with Axial Spondyloarthritis

    Tomas Cazenave1, Maria Celeste Orozco2, Gustavo Citera3, Emilce E Schneeberger1 and Marcos G. Rosemffet2, 1Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Rheumatology Section, Instituto de Rehabilitación Psicofísica, CABA, Argentina

    Background/Purpose: There is evidence that shows an increased cardiovascular risk in patients with Axial Spondyloarthritis (axSpA). Ultrasonography (US) is a simple imaging tool used to…
  • Abstract Number: 1651 • 2018 ACR/ARHP Annual Meeting

    Epidemiology of Depression and Anxiety in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis

    Enav Z. Zusman1,2,3, Alyssa Howren1,2,3, Jan Dutz4 and Mary A. De Vera1,2,3, 1Collaboration for Outcomes Research and Evaluation (CORE), Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 4Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Shared inflammatory processes underscore a substantial burden and risk of psychiatric complications – namely depression and anxiety – in patients with psoriatic arthritis (PsA),…
  • Abstract Number: 1652 • 2018 ACR/ARHP Annual Meeting

    Musculoskeletal Involvement in Inflammatory Bowel Disease’S Patients: A Mono Centric Experience

    Andrea Delle Sedie1, Linda Ceccarelli2, Linda Carli1, Francesco Costa3, Santino Marchi3 and Marta Mosca1, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2University Gastroenterology Unit, University of Pisa, Pisa, Italy, 3University Gastroenterology Unit, University of Pisa,, Pisa, Italy

    Background/Purpose: Musculoskeletal symptoms are frequently reported by patients with inflammatory bowel diseases (IBD). Those symptoms may vary from arthralgia to arthritis, involving peripheral or axial…
  • Abstract Number: 1653 • 2018 ACR/ARHP Annual Meeting

    Psychological Distress in Patients with Axial Spondyloarthritis in Europe. Results from the European Map of Axial Spondyloarthritis Survey

    Marco Garrido-Cumbrera1,2,3, David Galvez-Ruiz1,3, Laure Gossec4, Victoria Navarro-Compán5, Denis Poddubnyy6,7, Souzi Makri8, Raj Mahapatra9, Pedro Plazuelo-Ramos2, Carlos Jesus Delgado Dominguez1 and Christine Bundy10, 1Universidad de Sevilla, Seville, Spain, 2Spanish Coordinator of Spondyloarthritis Associations (CEADE), Madrid, Spain, 3Health & Territory Research (HTR), Seville, Spain, 4Sorbonne Universités, Paris, France, 5Immuno-Rheumatology research group, IdiPaz. La Paz University Hospital, Madrid, Spain, 6Rheumatology, Charité Universitätsmeidzin Berlin, Berlin, Germany, 7German Rheumatism Research Centre, Berlin, Germany, 8Cyprus League Against Rheumatism, Nicosia, Cyprus, 9Ankylosing Spondylitis International Federation (ASIF), London, United Kingdom, 10Cardiff University, Cardiff, United Kingdom

    Background/Purpose: To assess the association between sociodemographic characteristics, disease activity, and psychological distress in patients with axSpA. Methods: Between July 2017 and February 2018, 2,846…
  • Abstract Number: 1654 • 2018 ACR/ARHP Annual Meeting

    Improvement of Cytological Grade and Tear Production in Ankylosing Spondylitis Patients Under Anti-TNF Therapy: A Long-Term Follow-up

    Fany Usuba1, Carla GS Saad2, Priscila Novaes1, Ruth Santo1, Julio CB Moraes2, Eloisa Bonfa3 and Milton Alves4, 1Ophtalmology Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2Rheumatology Division, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3Rheumatology Division, Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil, 4Ophtalmolgy Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

    Background/Purpose: Clinical expression and pathophysiology of dry eye disease (DED) have recently changed and pro-inflammatory cytokines, such as TNF-α, may play a role in the…
  • Abstract Number: 1655 • 2018 ACR/ARHP Annual Meeting

    Achieving Remission in Psoriatic Arthritis By Early Initiation of TNF Inhibition: A Double-Blind, Randomized, Placebo-Controlled Trial of Golimumab + Methotrexate Versus Placebo + Methotrexate

    Leonieke van Mens1, Jet de Jong2, Inka Fluri1, Marleen van de Sande3, Michael Nurmohamed4, M.R. Kok5, Arno van Kuijk6 and Dominique Baeten2, 1Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 2Clinical Immunology and Rheumatology, Amsterdam Rheumatology and immunology Center, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3Clinical Immunology & Rheumatology, ARC | Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Rheumatology, Reade, Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 5Rheumatology, Maasstad Ziekenhuis, Rotterdam, Netherlands, 6Amsterdam Rheumatology and immunology Center, Reade, Amsterdam, Netherlands

    Background/Purpose: In inflammatory arthritis such as RA, early initiation of highly effective targeted treatments is a successful strategy to aim for sustained remission.1 Here we…
  • « Previous Page
  • 1
  • …
  • 1112
  • 1113
  • 1114
  • 1115
  • 1116
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology